CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease
Clinical Lymphoma Myeloma and Leukemia · 2023-10 · 23 (10) · 772-778
DOI: 10.1016/j.clml.2023.05.007 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2023-10. Verfasst von Uroosa Ibrahim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplant and Cellular Therapy/Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New…. Hauptthemen laut MEDLINE: Organ Transplantation, Kidney Transplantation, Lymphoproliferative Disorders, Epstein-Barr Virus Infections. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bone Marrow Transplant and Cellular Therapy/Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY. Electronic address: uroosa.ibrahim@mssm.edu.
- Department of Onconephrology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
- Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
- Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
- Bone Marrow Transplant and Cellular Therapy/Division of Hematology and Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, NY.
Zitieren
APA
Ibrahim, U., Bassil, C., Chavez, J. C., Khimani, F., Jain, M. D., Locke, F. L., Osman, K., & Lazaryan, A. (2023). CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease. Clinical Lymphoma Myeloma and Leukemia, 23(10), 772-778. https://doi.org/10.1016/j.clml.2023.05.007
Vancouver
Ibrahim U, Bassil C, Chavez JC, Khimani F, Jain MD, Locke FL, et al. CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease. Clinical Lymphoma Myeloma and Leukemia. 2023;23(10):772-778. doi:10.1016/j.clml.2023.05.007
BibTeX
@article{Ibrahim2023,
author = {Ibrahim, Uroosa and Bassil, Claude and Chavez, Julio C and Khimani, Farhad and Jain, Michael D and Locke, Frederick L and Osman, Keren and Lazaryan, Aleksandr},
title = {CAR T Cell Therapy for Post-Transplant Lymphoproliferative Disorder After Solid Organ Transplantation: A Safe and Feasible Therapy for an Orphan Disease},
journal = {Clinical Lymphoma Myeloma and Leukemia},
year = {2023},
volume = {23},
number = {10},
pages = {772--778},
doi = {10.1016/j.clml.2023.05.007}
}
EUVIMED